1. Home
  2. Live Updates
  3. Matthew biegler

Live Breaking News & Updates on Matthew biegler

Stay informed with the latest breaking news from Matthew biegler on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Matthew biegler and stay connected to the pulse of your community

These Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Results - ORIC Pharmaceuticals (NASDAQ:ORIC)

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported a loss for the fourth quarter on Monday.

Colleen-kusy , David-nierengarten , Matthew-biegler , Jacobm-chacko , Pharmaceuticals-inc ,

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript

Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44.

Michael-burry , Iain-fraser , Joseph-schwartz , Alex-sapir , Matthew-biegler , Corinne-johnson , Alan-musso , Glaxosmithkline , Fulcrum-therapeutics-inc , Nasdaq , Goldman-sachs

IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events

SOUTH SAN FRANCISCO, Calif., Feb. 1, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...

Darrin-beaupre , Andres-ruiz-briseno , Matthew-biegler , Yujiros-hata , Yigald-nochomovitz , Michael-white , Healthcare-life-sciences-conference , Exchange-commission , Biosciences-inc , Nasdaq , Annual-healthcare-life-sciences , Chief-executive-officer

Oppenheimer Says These 2 Beaten-Down Stocks Could Double Your Money — Here's Why They Could Rebound

Over the summer months the bull market that has defined 2023 so far has been taking a break. The question is, can it regain momentum and push ahead again? Or as Oppenheimer’s Chief Investment Strategist John Stoltzfus puts it, is it just “the pause that refreshes?” While Stoltzfus notes the potential for “some uptick in volatility” in the weeks and months ahead, his overall view of what’s to come next will be encouraging to investors. “We remain positive on the US economy and the equity markets,

Colin-rusch , Matthew-biegler , Soroush-salehian , Mina-rezk , John-stoltzfus , Pfizer , Arvinas-inc , Chief-investment-strategist-john-stoltzfus , Aeva-technologies , Light-detection , Frequency-modulated-continuous-wave , Moderate-buy

5 Stocks with Biggest Upside Potential According to Analysts

In this article, we will take a look at the 5 stocks with biggest upside potential according to analysts.

Matthew-biegler , Nasdaq , Carrick-therapeutics-ltd , Number-of-hedge-fund-holders , Pfizer-inc , Arvinas-inc , Biggest-upside-potential-according , Hedge-fund-holders , Connecticut-based-arvinas , Discovery-engine ,

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.

Canada , United-states , Alan-ezekowitz , Matthew-biegler , Judah-frommer , Alex-sapir , Esther-rajavelu , Madhu-kumar , Iain-fraser , Chris-calabrese , Edward-tenthoff , Robertj-gould

Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2023 Earnings Call Transcript

Operator: Good morning. My name is Kelly. And I'll be your conference operator today.

Salveen-richter , Matt-biegler , Jenna-cohen , Ernie-rodriguez , Andrew-berens , Kate-haviland , Raymond-james , Joel-beatty , Reni-benjamin , Zhiqiang-shu , Peter-lawson

Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2022 Earnings Call Transcript

Operator: Hello and thank you for standing by and welcome to Aptose Biosciences reports for the Fourth Quarter and Yearend 2022 Conference Call. At this time, all participants on a listen-only mode.

San-diego , California , United-states , Portugal , Canada , American , Canadian , Soumit-roy , Matthew-biegler , William-rice , Stephen-howell , Fletcher-payne

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.

United-states , Canada , Santiago , Regióetropolitana , Chile , America , Matt-biegler , Alan-ezekowitz , Acceleron-pharma , Robertj-gould , Iain-fraser , Madhu-kumar

IDEAYA Biosciences to Participate in Investor Conferences in March 2023

/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and...

Yujiros-hata , Matthew-biegler , Michael-white , Darrin-beaupre , Charles-zhu , Biosciences-inc , Exchange-commission , Equity-research-analyst , Nasdaq , Annual-healthcare-conference , Chief-scientific-officer , Chief-medical-officer